Blocking the CRMP4–dynein interaction reduces motor neuron loss in human-derived motor neurons and ALS model mice, suggesting a novel CRMP4-dependent retrograde death signal underlying motor neuron loss in ALS [140]. This evidence concerns the gene DPYSL3 and amyotrophic lateral sclerosis.